Michael P. Trova

537 total citations
23 papers, 396 citations indexed

About

Michael P. Trova is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Michael P. Trova has authored 23 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Michael P. Trova's work include Synthetic Organic Chemistry Methods (6 papers), Asymmetric Synthesis and Catalysis (5 papers) and Chemical Synthesis and Analysis (3 papers). Michael P. Trova is often cited by papers focused on Synthetic Organic Chemistry Methods (6 papers), Asymmetric Synthesis and Catalysis (5 papers) and Chemical Synthesis and Analysis (3 papers). Michael P. Trova collaborates with scholars based in United States, Netherlands and United Kingdom. Michael P. Trova's co-authors include Leo A. Paquette, Stephen Bocckino, James D. Crapo, Brian J. Day, Rick Danheiser, Atsushi Nishida, Allan Wissner, Kevin F. McGee, Larry B. Anderson and S.S. Kerwar and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Michael P. Trova

23 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael P. Trova United States 11 229 113 71 58 40 23 396
Mariko Aso Japan 14 323 1.4× 175 1.5× 64 0.9× 41 0.7× 41 1.0× 47 541
Boyu Zhong United States 13 364 1.6× 207 1.8× 54 0.8× 63 1.1× 39 1.0× 26 590
Carina Storm Poulsen Denmark 5 293 1.3× 153 1.4× 38 0.5× 26 0.4× 30 0.8× 6 403
John Scheigetz Canada 16 334 1.5× 258 2.3× 46 0.6× 59 1.0× 65 1.6× 35 593
M. Soledad Pino-González Spain 15 407 1.8× 212 1.9× 80 1.1× 26 0.4× 28 0.7× 44 522
Natarajan Srinivasan United Kingdom 14 430 1.9× 224 2.0× 57 0.8× 58 1.0× 26 0.7× 22 586
Edward Brown United States 13 425 1.9× 324 2.9× 42 0.6× 39 0.7× 41 1.0× 26 749
Kenneth L. Kees United States 11 615 2.7× 168 1.5× 48 0.7× 71 1.2× 66 1.6× 15 758
David C. Ebner United States 13 520 2.3× 133 1.2× 42 0.6× 122 2.1× 36 0.9× 20 669
Thomas J. Delia United States 12 347 1.5× 164 1.5× 62 0.9× 34 0.6× 14 0.3× 45 480

Countries citing papers authored by Michael P. Trova

Since Specialization
Citations

This map shows the geographic impact of Michael P. Trova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Trova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Trova more than expected).

Fields of papers citing papers by Michael P. Trova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Trova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Trova. The network helps show where Michael P. Trova may publish in the future.

Co-authorship network of co-authors of Michael P. Trova

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Trova. A scholar is included among the top collaborators of Michael P. Trova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Trova. Michael P. Trova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trova, Michael P., et al.. (2012). PV Inverter Extended Grid Services – From “Day-Time” to “Full-Time” Operation. EU PVSEC. 3811–3821. 2 indexed citations
2.
Trova, Michael P., Keith D. Barnes, John M. Lehman, et al.. (2009). Biaryl purine derivatives as potent antiproliferative agents: Inhibitors of cyclin dependent kinases. Part I. Bioorganic & Medicinal Chemistry Letters. 19(23). 6608–6612. 14 indexed citations
3.
Trova, Michael P., Keith D. Barnes, Simon N. Haydar, et al.. (2009). Heterobiaryl purine derivatives as potent antiproliferative agents: Inhibitors of cyclin dependent kinases. Part II. Bioorganic & Medicinal Chemistry Letters. 19(23). 6613–6617. 14 indexed citations
4.
Trova, Michael P., et al.. (2003). Superoxide dismutase mimetics. Part 2: synthesis and structure–Activity relationship of glyoxylate- and glyoxamide-Derived metalloporphyrins. Bioorganic & Medicinal Chemistry. 11(13). 2695–2707. 51 indexed citations
5.
Trova, Michael P., et al.. (2002). Superoxide dismutase mimetics: synthesis and structure–activity relationship study of MnTBAP analogues. Bioorganic & Medicinal Chemistry. 10(9). 3013–3021. 70 indexed citations
7.
Herr, R. Jason, et al.. (2001). Preparation of 8-Substituted Xanthine CVT-124 Precursor by Late Stage Pyrimidine Ring Closure. The Journal of Organic Chemistry. 67(1). 188–193. 4 indexed citations
8.
Herr, R. Jason, et al.. (2000). Synthesis of enantiomerically pure (+)- and (−)-18-methoxycoronaridine hydrochloride and Their preliminary assessment as anti-addictive agents. Bioorganic & Medicinal Chemistry Letters. 10(5). 473–476. 11 indexed citations
9.
10.
Danheiser, Rick & Michael P. Trova. (1995). Synthesis of Linear Furocoumarins via a Photochemical Aromatic Annulation Strategy. An Efficient Total Synthesis of Bergapten. Synlett. 1995(SI). 573–574. 9 indexed citations
11.
Trova, Michael P. & Kevin F. McGee. (1995). Asymmetric synthesis of optically active decahydroisoquinolines useful in HIV-1 protease inhibitor synthesis. Tetrahedron. 51(21). 5951–5954. 7 indexed citations
12.
Trova, Michael P., et al.. (1994). Asymmetric synthesis of cis- and trans-γ-lactones useful in HIV-1 protease inhibitor synthesis. Bioorganic & Medicinal Chemistry Letters. 4(7). 903–906. 7 indexed citations
13.
Trova, Michael P., Allan Wissner, Marion L. Carroll, et al.. (1993). Analogs of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring. Journal of Medicinal Chemistry. 36(5). 580–590. 9 indexed citations
14.
Trova, Michael P., et al.. (1993). Synthesis of C2-symmetric compounds via double alkylation of (α,ω-dioxo-alkanediyl)bis-2-oxazolidinone derivatives. Tetrahedron. 49(20). 4147–4158. 6 indexed citations
15.
Trova, Michael P., Robert E. Babine, Randal A. Byrn, et al.. (1993). Synthesis and biological evaluation of a series of HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 3(8). 1595–1600. 9 indexed citations
16.
Wissner, Allan, Marion L. Carroll, Bernard D. Johnson, et al.. (1992). Analogs of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF. Journal of Medicinal Chemistry. 35(26). 4779–4789. 10 indexed citations
17.
Paquette, Leo A., et al.. (1990). Synthesis and dynamic behavior of (1,5)cyclooctatetraenophanes. Effect of distal atom bridging on racemization rates and electrochemical reducibility. Journal of the American Chemical Society. 112(1). 228–239. 18 indexed citations
18.
Anet, Frank A. L., et al.. (1989). Dynamics of seven- and eight-membered 1,5-cycloalkane-fused semibullvalene derivatives. Tetrahedron Letters. 30(47). 6469–6472. 3 indexed citations
19.
Paquette, Leo A. & Michael P. Trova. (1988). Dynamic properties of chiral cyclooctatetraenes. Total inhibition of the racemization process by 1,4-annulation. Journal of the American Chemical Society. 110(24). 8197–8201. 7 indexed citations
20.
Danheiser, Rick, et al.. (1988). Trialkylsilyloxyalkynes: Synthesis and aromatic annulation reactions. Tetrahedron Letters. 29(39). 4917–4920. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026